文献速递精神分裂症与精神病性障碍会诊联络精神医学

精神分裂症合并糖尿病患者的死亡与并发症风险:一项基于人群的队列研究

Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population-based cohort study.
PubMed 文献 · Br J Psychiatry · 2021-01-01

结果显示精神分裂症与全因死亡风险升高相关(aHR 1.11,95%CI 1.05-1.18),代谢并发症风险更高(aHR 1.99),微血管并发症风险更低(aHR 0.75),大血管并发症风险相当;发生并发症后全因死亡风险亦升高。

要点

  • 精神分裂症合并糖尿病患者全因死亡风险升高(aHR 1.11,95%CI 1.05-1.18)。
  • 代谢并发症风险更高(aHR 1.99),微血管并发症风险更低(aHR 0.75)。
  • 大血管或微血管并发症后全因死亡风险均升高,男性更显著。

核心结论

  • 精神分裂症合并糖尿病患者存在超额死亡风险,包括并发症后死亡风险升高。

主要发现

  • 精神分裂症与全因死亡风险升高相关(aHR 1.11,95%CI 1.05-1.18),在男性和较年长组中更明显。
  • 精神分裂症患者代谢并发症发生率更高(aHR 1.99,95%CI 1.63-2.42)。
  • 精神分裂症患者微血管并发症发生率更低(aHR 0.75,95%CI 0.65-0.86)。
  • 精神分裂症患者大血管并发症发生率与仅糖尿病患者相当(aHR 0.93,95%CI 0.85-1.03)。
  • 在发生糖尿病并发症的患者中,精神分裂症与大血管并发症后全因死亡升高相关(aHR 1.19,95%CI 1.04-1.37),也与微血管并发症后全因死亡升高相关(aHR 1.33,95%CI 1.08-1.64)。

临床怎么用

  • 对精神分裂症合并糖尿病患者应加强代谢监测与综合管理,以降低超额死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Schizophrenia patients have markedly elevated prevalence of diabetes compared with the general population. However, risk of mortality and diabetes-related complications among schizophrenia patients with co-occurring diabetes is understudied. AIMS: We investigated whether schizophrenia increased the risk of overall mortality, complications and post-complication mortality in people with diabetes. METHOD: This population-based, propensity-score matched (1:10) cohort study identified 6991 patients with incident diabetes and pre-existing schizophrenia and 68 682 patients with incident diabetes only between 2001 and 2016 in Hong Kong using a medical record database of public healthcare services. Association between schizophrenia and all-cause mortality was examined with a Cox proportional hazards model. Effect of schizophrenia on first-year complication occurrence following diabetes diagnosis and post-complication mortality rates were evaluated. RESULTS: Schizophrenia was associated with increased all-cause mortality (adjusted hazards ratio [aHR] 1.11, 95% CI 1.05-1.18), particularly among men and older age groups. Schizophrenia patients with diabetes had higher metabolic complication rate (aHR 1.99, 95% CI 1.63-2.42), lower microvascular complication rate (aHR 0.75, 95% CI 0.65-0.86) and comparable macrovascular complication rate (aHR 0.93, 95% CI 0.85-1.03), relative to patients with diabetes only. Among patients with diabetes complications, schizophrenia was associated with elevated all-cause mortality after macrovascular (aHR 1.19, 95% CI 1.04-1.37) and microvascular (aHR 1.33, 95% CI 1.08-1.64) complications. Gender-stratified analyses revealed that a significant effect of schizophrenia on heightened post-complication mortality was observed in men only. CONCLUSIONS: Schizophrenia patients with co-occurring diabetes are at increased risk of excess mortality, including post-complication mortality. Further research identifying effective interventions is warranted to optimise diabetes-related outcomes in this vulnerable population.

来源:Br J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Chan JKN, Wong CSM, Or PCF, et al. Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population-based cohort study. Br J Psychiatry. 2021. PMID: 33407970. doi:10.1192/bjp.2020.248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。